Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMEGPSW)

Drug Name

AdCh63 AMA1 Drug Info

Synonyms

MVA AMA1; Recombinant adenovirus-poxvirus prime-boost malaria vaccine, Oxford University/MRC/Wellcome

Indication

Disease Entry	ICD 11	Status	REF
Malaria	1F40-1F45	Phase 1/2	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Plasmodium Apical membrane protein (Malaria AMA-1)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
DNA-Ad	DM71BFM	Malaria	1F40-1F45	Phase 1/2	[2]
PfAMA-1	DMLDZX1	Malaria	1F40-1F45	Phase 1	[3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Plasmodium Apical membrane protein (Malaria AMA-1)	TTQZW34	AMA1_PLAFF	Not Available	[1]

------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT01142765) Study to Assess Efficacy of New Malaria Vaccine Candidates AdCh63 AMA1, MVA AMA1, AdCh63 MSP1, MVA MSP1, AdCh63 ME-TRAP & MVA ME-TRAP. U.S. National Institutes of Health.
2	Sterile immunity to malaria after DNA prime/adenovirus boost immunization is associated with effector memory CD8+T cells targeting AMA1 class I epitopes. PLoS One. 2014 Sep 11;9(9):e106241.
3	Plasmodium falciparum apical membrane antigen 1 (PfAMA-1) is translocated within micronemes along subpellicular microtubules during merozoite devel... J Cell Sci. 2003 Sep 15;116(Pt 18):3825-34.